152 related articles for article (PubMed ID: 12594286)
1. Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.
Precopio ML; Sullivan JL; Willard C; Somasundaran M; Luzuriaga K
J Immunol; 2003 Mar; 170(5):2590-8. PubMed ID: 12594286
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
3. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
[TBL] [Abstract][Full Text] [Related]
4. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
[TBL] [Abstract][Full Text] [Related]
5. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
6. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype.
Maini MK; Gudgeon N; Wedderburn LR; Rickinson AB; Beverley PC
J Immunol; 2000 Nov; 165(10):5729-37. PubMed ID: 11067931
[TBL] [Abstract][Full Text] [Related]
7. Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.
Scherrenburg J; Piriou ER; Nanlohy NM; van Baarle D
Clin Exp Immunol; 2008 Aug; 153(2):231-9. PubMed ID: 18549439
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.
Long HM; Leese AM; Chagoury OL; Connerty SR; Quarcoopome J; Quinn LL; Shannon-Lowe C; Rickinson AB
J Immunol; 2011 Jul; 187(1):92-101. PubMed ID: 21622860
[TBL] [Abstract][Full Text] [Related]
9. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
10. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
Catalina MD; Sullivan JL; Bak KR; Luzuriaga K
J Immunol; 2001 Oct; 167(8):4450-7. PubMed ID: 11591771
[TBL] [Abstract][Full Text] [Related]
11. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
13. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
[TBL] [Abstract][Full Text] [Related]
14. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.
Long HM; Chagoury OL; Leese AM; Ryan GB; James E; Morton LT; Abbott RJ; Sabbah S; Kwok W; Rickinson AB
J Exp Med; 2013 May; 210(5):933-49. PubMed ID: 23569328
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.
Catalina MD; Sullivan JL; Brody RM; Luzuriaga K
J Immunol; 2002 Apr; 168(8):4184-91. PubMed ID: 11937579
[TBL] [Abstract][Full Text] [Related]
16. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
[TBL] [Abstract][Full Text] [Related]
17. Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.
Ning RJ; Xu XQ; Chan KH; Chiang AK
Immunology; 2011 Oct; 134(2):161-71. PubMed ID: 21896011
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis.
Hoshino Y; Nishikawa K; Ito Y; Kuzushima K; Kimura H
J Clin Virol; 2011 Mar; 50(3):244-6. PubMed ID: 21185773
[TBL] [Abstract][Full Text] [Related]
19. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
Woodberry T; Suscovich TJ; Henry LM; Davis JK; Frahm N; Walker BD; Scadden DT; Wang F; Brander C
J Infect Dis; 2005 Nov; 192(9):1513-24. PubMed ID: 16206065
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential.
Dunne PJ; Faint JM; Gudgeon NH; Fletcher JM; Plunkett FJ; Soares MV; Hislop AD; Annels NE; Rickinson AB; Salmon M; Akbar AN
Blood; 2002 Aug; 100(3):933-40. PubMed ID: 12130505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
